Project Details
Description
Characterization and Quantitation of DNA Adducts Resulting from the Hypoxia-activated Prodrug (HAP) CP-506 and its Amine Metabolite CP-506M
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/18 → 6/30/19 |
Funding
- CONVERT PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.